
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025
Description
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prostate cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for prostate cancer nuclear medicine diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prostate cancer nuclear medicine diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Single Photon Emission Computed Tomography (SPECT); Photon Emission Computed Tomography (PET)
2) By Test Type: Preliminary Tests; Confirmatory Tests
3) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Single Photon Emission Computed Tomography (SPECT): Gamma Camera SPECT; Hybrid SPECT Or CT Imaging
2) By Positron Emission Tomography (PET): PET Or CT Imaging; PET Or MRI Imaging
Companies Mentioned: Cardinal Health; General Electric; Bayer AG; Novartis AG; Siemens Healthineers AG; GE Healthcare; Lantheus; CURIUM PHARMA; Telix Pharmaceuticals Ltd.; Eckert & Ziegler AG; Point Biopharma Global Inc.; Point Biopharma; Alliance Medical Ltd.; SHINE Medical Technologies LLC; PETNET Solution; NorthStar Medical Radioisotopes LLC; Global Medical Solutions LLC; Isotope Technologies Garching (ITG); Jubilant Pharma Limited; Blue Earth Diagnostics Inc.; Institute of Isotopes Co. Ltd.; Radiopharm Theranostics; Bracco Diagnostic Inc.; NCM-USA LLC; ABX Advanced Biochemical Compounds GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on prostate cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prostate cancer nuclear medicine diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prostate cancer nuclear medicine diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Single Photon Emission Computed Tomography (SPECT); Photon Emission Computed Tomography (PET)
2) By Test Type: Preliminary Tests; Confirmatory Tests
3) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Single Photon Emission Computed Tomography (SPECT): Gamma Camera SPECT; Hybrid SPECT Or CT Imaging
2) By Positron Emission Tomography (PET): PET Or CT Imaging; PET Or MRI Imaging
Companies Mentioned: Cardinal Health; General Electric; Bayer AG; Novartis AG; Siemens Healthineers AG; GE Healthcare; Lantheus; CURIUM PHARMA; Telix Pharmaceuticals Ltd.; Eckert & Ziegler AG; Point Biopharma Global Inc.; Point Biopharma; Alliance Medical Ltd.; SHINE Medical Technologies LLC; PETNET Solution; NorthStar Medical Radioisotopes LLC; Global Medical Solutions LLC; Isotope Technologies Garching (ITG); Jubilant Pharma Limited; Blue Earth Diagnostics Inc.; Institute of Isotopes Co. Ltd.; Radiopharm Theranostics; Bracco Diagnostic Inc.; NCM-USA LLC; ABX Advanced Biochemical Compounds GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Primary Care POC Diagnostics Market Characteristics
- 3. Primary Care POC Diagnostics Market Trends And Strategies
- 4. Primary Care POC Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Primary Care POC Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Primary Care POC Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Primary Care POC Diagnostics Market Growth Rate Analysis
- 5.4. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Primary Care POC Diagnostics Total Addressable Market (TAM)
- 6. Primary Care POC Diagnostics Market Segmentation
- 6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Glucose Monitoring
- Cardiometabolic Testing Products
- Infectious Disease Testing Products
- Coagulation Testing Products
- Pregnancy And Fertility Testing Products
- Tumor Or Cancer Marker Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drug-Of-Abuse (DOA) Testing Products
- Other Products
- 6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prescription Based
- Over-The-Counter (OTC) Testing
- 6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Home-Care Settings
- Other End-Uses
- 6.4. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Glucose Meters
- Continuous Glucose Monitoring (Cgm) Systems
- Test Strips For Glucose Meters
- Glucose Control Solutions
- 6.5. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cardiometabolic Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Pressure Monitors
- Lipid Profile Testing Kits
- Hemoglobin A1c Testing Kits
- Ecg Or Ecg Monitors
- Hba1c Point-Of-Care Devices
- 6.6. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Infectious Disease Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Rapid Strep Tests
- Influenza (Flu) Testing Kits
- Covid-19 Rapid Tests
- Hiv Rapid Testing Kits
- Hepatitis Testing Kits
- Malaria Rapid Diagnostic Tests (Rdts)
- Other Infectious Disease Tests
- 6.7. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Coagulation Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prothrombin Time (Pt) Testing Kits
- International Normalized Ratio (Inr) Monitors
- Activated Partial Thromboplastin Time (Aptt) Testing Kits
- Coagulation Control Solutions
- Whole Blood Coagulation Monitors
- 6.8. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Pregnancy And Fertility Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Home Pregnancy Tests (Urine-Based)
- Ovulation Prediction Kits
- Pregnancy Test Strips
- Fertility Monitoring Devices
- 6.9. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Tumor Or Cancer Marker Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Psa (Prostate-specific Antigen) Testing Kits
- Cea (Carcinoembryonic Antigen) Testing Kits
- Ca-125 (Ovarian Cancer Marker) Kits
- Her2 Testing Kits
- Other Tumor Marker Test Kits
- 6.10. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cholesterol Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Total Cholesterol Testing Kits
- Ldl Or Hdl Testing Kits
- Triglyceride Testing Kits
- Point-Of-Care Lipid Panel Devices
- 6.11. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Hematology Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hemoglobin Test Kits
- Hematocrit Testing Kits
- Complete Blood Count (Cbc) Kits
- Point-Of-Care Hematology Analyzers
- Hemoglobin A1c Testing Devices
- 6.12. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Drug-Of-Abuse (Doa) Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urine Drug Tests
- Oral Fluid Drug Tests
- Saliva-Based Drug Tests
- Blood-Based Drug Tests
- Breath Alcohol Tests
- 6.13. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergy Testing Kits
- Urinalysis Test Strips
- Vitamin And Mineral Deficiency Testing Kits
- Point-Of-Care Liver Function Tests
- Kidney Function Testing Products
- Blood Gas Testing Devices
- 7. Primary Care POC Diagnostics Market Regional And Country Analysis
- 7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Primary Care POC Diagnostics Market
- 8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Primary Care POC Diagnostics Market
- 9.1. China Primary Care POC Diagnostics Market Overview
- 9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Primary Care POC Diagnostics Market
- 10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Primary Care POC Diagnostics Market
- 11.1. Japan Primary Care POC Diagnostics Market Overview
- 11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Primary Care POC Diagnostics Market
- 12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Primary Care POC Diagnostics Market
- 13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Primary Care POC Diagnostics Market
- 14.1. South Korea Primary Care POC Diagnostics Market Overview
- 14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Primary Care POC Diagnostics Market
- 15.1. Western Europe Primary Care POC Diagnostics Market Overview
- 15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Primary Care POC Diagnostics Market
- 16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Primary Care POC Diagnostics Market
- 17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Primary Care POC Diagnostics Market
- 18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Primary Care POC Diagnostics Market
- 19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Primary Care POC Diagnostics Market
- 20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Primary Care POC Diagnostics Market
- 21.1. Eastern Europe Primary Care POC Diagnostics Market Overview
- 21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Primary Care POC Diagnostics Market
- 22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Primary Care POC Diagnostics Market
- 23.1. North America Primary Care POC Diagnostics Market Overview
- 23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Primary Care POC Diagnostics Market
- 24.1. USA Primary Care POC Diagnostics Market Overview
- 24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Primary Care POC Diagnostics Market
- 25.1. Canada Primary Care POC Diagnostics Market Overview
- 25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Primary Care POC Diagnostics Market
- 26.1. South America Primary Care POC Diagnostics Market Overview
- 26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Primary Care POC Diagnostics Market
- 27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Primary Care POC Diagnostics Market
- 28.1. Middle East Primary Care POC Diagnostics Market Overview
- 28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Primary Care POC Diagnostics Market
- 29.1. Africa Primary Care POC Diagnostics Market Overview
- 29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Primary Care POC Diagnostics Market Competitive Landscape
- 30.2. Primary Care POC Diagnostics Market Company Profiles
- 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Becton, Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
- 31. Primary Care POC Diagnostics Market Other Major And Innovative Companies
- 31.1. Quidel Corporation
- 31.2. Sysmex Corporation
- 31.3. Bio-Rad Laboratories Inc.
- 31.4. Nova Biomedical Corporation
- 31.5. Randox Laboratories Ltd
- 31.6. Ortho Clinical Diagnostics
- 31.7. Nipro Corporation
- 31.8. OraSure Technologies
- 31.9. Meridian Bioscience Inc
- 31.10. DiaSorin SpA
- 31.11. Sekisui Diagnostics LLC
- 31.12. EKF Diagnostics Holdings plc
- 31.13. Trinity Biotech plc
- 31.14. Fujirebio Diagnostics Inc.
- 31.15. Immunodiagnostic Systems Holdings PLC
- 32. Global Primary Care POC Diagnostics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market
- 34. Recent Developments In The Primary Care POC Diagnostics Market
- 35. Primary Care POC Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Primary Care POC Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Primary Care POC Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Primary Care POC Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.